AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Glimison-M 1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Unison Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimison-M 1 Tablet PR

Diabetacomb-1, a dual-action antidiabetic medication, manages type 2 diabetes in adults. This formulation combines two agents to regulate blood glucose. Administer Diabetacomb-1 with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continue this treatment even with controlled blood sugar; abrupt cessation, without physician consultation, risks elevated glucose, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Diabetacomb-1 is part of a comprehensive plan encompassing diet, exercise, and weight management as advised by your healthcare provider. Lifestyle modifications are crucial for diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect, manifesting as sweating, dizziness, headache, and tremors. Maintain regular meals and carry readily available glucose sources (e.g., sweets, juice) to counteract this. Alcohol elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. Diabetacomb-1 is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your doctor before use, as it may be unsuitable. Pregnant or lactating individuals require physician consultation prior to use. Routine blood glucose checks and potential blood tests (blood counts, liver function) are necessary as directed by your physician.

Primary Ingredients of Glimison-M 1 Tablet PR

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Glimison-M 1 Tablet PR

Managing type 2 diabetes

Major Benefits of Glimison-M 1 Tablet PR:

Follow your physician's instructions or consult the product label for guidance. Take one Glimison-M PR tablet with a meal.

Common Side effects of Glimison-M 1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimison-M 1 Tablet PR:

Follow your doctor's instructions or the product label for proper administration. Take one Glimison-M PR tablet with food.

How Glimison-M 1 Tablet PR works:

Glimison-M PR, a single-tablet formulation, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimison-M 1 Tablet PR with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimison-M 1 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Maternal use of Glimison-M 1 Tablet PR while breastfeeding is contraindicated due to potential infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimison-M 1 Tablet PR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Physician consultation is advised. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Glimison-M 1 Tablet PR to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician. For patients exhibiting mild to moderate liver dysfunction, initiate Glimison-M 1 Tablet PR therapy at a reduced dosage; its use is contraindicated in cases of severe liver disease.

What if you forget to take Glimison-M 1 Tablet PR :

Should you forget to take a Glimison-M 1 Tablet PR, ingest it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the forgotten dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimison-M 1 Tablet PR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Glimison-M 1 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimison-M 1 Tablet PR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare but harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimison-M 1 Tablet PR and seek immediate medical attention.
Glimison-M 1 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. It enhances blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 DM.
Glimison-M 1 Tablet PR may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glimison-M 1 Tablet PR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, neurological issues like tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Glimison-M 1 Tablet PR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimison-M 1 Tablet PR with alcohol is unsafe. This combination can dangerously lower blood sugar, causing hypoglycemia, and increase the risk of lactic acidosis.
Glimison-M 1 Tablet PR
34
MRP 39
13% off